A case of metachronous peripheral T‐Cell non‐Hodgkin lymphoma following chemotherapy for Hodgkin disease successfully treated with brentuximab vedotin [PDF]
Clinical Case Reports, 2020 Occasionally, non‐Hodgkin lymphomas (NHL) occur simultaneously or subsequently to Hodgkin disease. We report on a case of a woman with Hodgkin lymphoma treated with ABVD, who developed 4 years later T‐cell NHL with both nodal and extranodal involvement ...
Federico Meconi +9 more
doaj +2 more sources
Hodgkin Disease—An Ever-Evolving Therapy [PDF]
Rambam Maimonides Medical Journal, 2014 Therapy of Hodgkin lymphoma (HL) is a rapidly changing field due to plenty of currently emerging data. Treatment approaches are currently based on tailoring of therapy in order to achieve a maximal response with minimal toxicity.
Eldad J. Dann
doaj +2 more sources
Hematology, Transfusion and Cell TherapyHodgkin Lymphoma (HL) is a B-cell malignancy accounting for approximately 10% of all lymphoma cases and 5% of lymphoma-related mortalities. Incidence increases in younger adults and those above 55-years of age and has a bimodal distribution ...
Valeh Huseynov
openalex +3 more sources
Impact of Cox2, CD163, and Microvessel Density Expression on the Prediction of Relapse and Patients’ Outcome in Classical Hodgkin Lymphoma [PDF]
Middle East Journal of Cancer, 2022 Background: Tumor microenvironment, specifically tumor-associated macrophages, plays an important role in tumor initiation and progression. CD163 has been recognized as a valuable specific macrophage marker.
Rania Makboul +6 more
doaj +1 more source
Classical Hodgkin lymphoma following follicular lymphoma: a case report [PDF]
Journal of Yeungnam Medical Science, 2023 The simultaneous, composite, or sequential occurrence of follicular lymphoma (FL) and classical Hodgkin lymphoma (HL), both of which originate from germinal center B-cell, is rare.
Bomi Kim
doaj +1 more source
Immune Thrombocytopenic Purpura Evolving into Hodgkin’s Disease in a Young Boy [PDF]
Bengal Physician Journal, 2022 Immune thrombocytopenic purpura (ITP) is a common bleeding disorder, and it may be primary (no potential etiologies found) or secondary (underlying associated conditions).
Karimulla Mondal +4 more
doaj +1 more source
Cell Reports, 2023 Summary: Variants at the GBA locus, encoding glucocerebrosidase, are the strongest common genetic risk factor for Parkinson’s disease (PD). To understand GBA-related disease mechanisms, we use a multi-part-enrichment proteomics and post-translational ...
Helle Bogetofte +22 more
doaj +1 more source
Digital Clubbing and Hodgkin Disease in Children: A Case Report and Review of Literature
Journal of Pediatrics Review, 2021 Introduction: Digital clubbing (hypertrophic osteoarthropathy) as the initial presentation of lymphoma is rarely reported, particularly in children. In this study, we report a patient with intrathoracic Hodgkin Disease (HD) and digital clubbing as the ...
Hossein Karami +6 more
doaj +1 more source
Tuberculous Adenitis with Concurrent Hodgkin Lymphoma: A Case Report
Oman Medical Journal, 2020 The concomitant occurrence of tuberculous adenitis and Hodgkin lymphoma is rare, posing a diagnostic dilemma since both have similar symptoms, such as lymphadenopathy, weight loss, fever, and night sweats.
Fahmi Yousef Khan +4 more
doaj +1 more source
Serum biomarkers and clinical characteristics of patients with Hodgkin lymphoma [PDF]
Vojnosanitetski Pregled, 2018 Background/Aim. In classical Hodgkin’s lymphoma (cHL) the existing prognostic scoring systems do not include markers that adequately reflect the interaction of malignant Hodgkin and Reed-Sternberg (HRS) cells and tumor environment.
Simonović Olivera +6 more
doaj +1 more source